Leveraging Synthetic Biology for Resilient Pharma Supply Chains and Accessible Medicines
![](https://antheia.bio/wp-content/uploads/2023/05/Leveraging-Synthetic-Biology-for-Resilient-Pharma-Supply-Chains-and-Accessible-Medicines.png)
Antheia was founded in 2015 by Dr. Christina Smolke, CEO and Dr. Kristy Hawkins, CSO and is based in Menlo Park, California. Antheia’s co-founders are pioneers in the fields of synthetic biology and metabolic engineering and are applying these technologies to transform pharmaceutical supply chains in order to better support the needs of 21st century healthcare.
Advancing the U.S. Bioeconomy and Building Resilient Pharmaceutical Supply Chains
![Advancing the U.S. Bioeconomy and Building Resilient Pharmaceutical Supply Chains](https://antheia.bio/wp-content/uploads/2023/05/Advancing-the-U.S.-Bioeconomy-and-Building-Resilient-Pharmaceutical-Supply-Chains.png)
We continue to see the U.S. government setting policy priorities that underscore the importance of both building a robust American bioeconomy and strengthening domestic pharmaceutical supply chains – two core pillars of Antheia’s business and technology.
Synthetic Chemistry in Pharma
![](https://antheia.bio/wp-content/uploads/2023/05/Synthetic-Chemistry-in-Pharma.png)
Synthetic chemistry is an essential part of drug development, opening the door for scientists to create complex small molecules with specific properties. Small molecule drugs – including household staples like aspirin and acetaminophen – currently make up the bulk of approved pharmaceuticals to date.
Could synthetic biology solutions fix supply chain challenges?
![](https://antheia.bio/wp-content/uploads/2021/05/MaisonAntheia-130-1.png)
An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes…
COVID-19 Vaccine Transforms Pharma Supply Chain Forever
![](https://antheia.bio/wp-content/uploads/2021/03/Frame-4.png)
The intricacies of the pharmaceutical supply chain may not have been in the mainstream news a few years ago, but recent events kicked this subject to front page news…
The Drug Supply Chain Is Broken. A New Breakthrough Paves The Way For On-Demand Plant-Based Medicine
![](https://antheia.bio/wp-content/uploads/2020/09/louis-reed-pwcKF7L4-no-unsplash-1.png)
When Covid hit and hospitals started reporting shortages of hydroxychloroquine and other medicines vital to patients with conditions like malaria, lupus, asthma, and COPD, it became clear that our drug supply chain was broken…
As Featured in STAT: The pharma supply chain is broken. Synthetic biology could fix it.
![](https://antheia.bio/wp-content/uploads/2023/05/image-16500.png)
We started Antheia four years ago with a steadfast commitment to help build a more robust drug supply chain – one that delivers the right medicines to the right people, at the right time. In the era of COVID-19, this work is more important than ever before…
The Journey of a Pill
![](https://antheia.bio/wp-content/uploads/2023/05/image-165000.png)
mericans spend over $300 billion on pharmaceutical drugs every year. In normal times, the supply chain behind these drugs is designed to go unnoticed…
Modern Medicine’s Ancient Roots
![](https://antheia.bio/wp-content/uploads/2023/05/image-1650000.png)
For thousands of years, communities across cultures and geographies have relied on the inherent healing properties of plants. Ancient Greek physicians prized mint for treating digestive issues and it is used frequently today in the…